See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
0
0
$0.00
$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Mar 27, 2026 Manning Meredith |
Manning Meredith
Chief Commercial Officer
|
Sell |
4,864 | $30.04 | 4,864 $30.04 $146,100 |
Mar 27, 2026 Manning Meredith |
Manning Meredith
Chief Commercial Officer
|
Sell |
2,100 | $31.04 | 2,100 $31.04 $65,181 |
Mar 27, 2026 Manning Meredith |
Manning Meredith
Chief Commercial Officer
|
Sell |
558 | $31.72 | 558 $31.72 $17,699 |
Mar 27, 2026 Huang Michael F. |
Huang Michael F.
Sr. VP of Clinical Development
|
Sell |
4,256 | $30.04 | 4,256 $30.04 $127,837 |
Mar 27, 2026 Huang Michael F. |
Huang Michael F.
Sr. VP of Clinical Development
|
Sell |
1,838 | $31.04 | 1,838 $31.04 $57,049 |
Mar 27, 2026 Huang Michael F. |
Huang Michael F.
Sr. VP of Clinical Development
|
Sell |
488 | $31.72 | 488 $31.72 $15,479 |
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jul 01, 2025 Hirano Patricia C |
Hirano Patricia C
See Remarks
|
Sell |
3,830 | $82.76 | 3,830 $82.76 $316,971 |
Jun 24, 2025 Hirano Patricia C |
Hirano Patricia C
See Remarks
|
Sell |
266 | $84.25 | 266 $84.25 $22,411 |
Apr 01, 2025 Hirano Patricia C |
Hirano Patricia C
See Remarks
|
Sell |
3,782 | $70.11 | 3,782 $70.11 $265,156 |
Mar 28, 2025 Pauls Matthew |
Pauls Matthew
|
Sell |
5,937 | $71.55 | 5,937 $71.55 $424,797 |
Mar 28, 2025 Vivo Opportunity, LLC |
Vivo Opportunity, LLC
|
Sell |
333,557 | $70.60 | 333,557 $70.60 $23,549,124 |
Mar 27, 2025 Mackaness James H |
Mackaness James H
CFO
|
Sell |
6,498 | $68.79 | 6,498 $68.79 $446,985 |
Mar 27, 2025 Mackaness James H |
Mackaness James H
CFO
|
Sell |
1,669 | $65.97 | 1,669 $65.97 $110,102 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
2,881 | $66.79 | 2,881 $66.79 $192,427 |
Mar 27, 2025 Mackaness James H |
Mackaness James H
CFO
|
Sell |
86 | $72.64 | 86 $72.64 $6,247 |
Mar 27, 2025 Mackaness James H |
Mackaness James H
CFO
|
Sell |
563 | $71.74 | 563 $71.74 $40,391 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
1,769 | $65.97 | 1,769 $65.97 $116,699 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
50,156 | $66.00 | 50,156 $66.00 $3,310,080 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
91 | $72.64 | 91 $72.64 $6,610 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
3,990 | $69.84 | 3,990 $69.84 $278,650 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
411 | $70.73 | 411 $70.73 $29,072 |
Mar 27, 2025 Huang Michael F. |
Huang Michael F.
Sr. VP of Clinical Development
|
Sell |
10,000 | $70.03 | 10,000 $70.03 $700,330 |
Mar 27, 2025 Mackaness James H |
Mackaness James H
CFO
|
Sell |
2,717 | $66.79 | 2,717 $66.79 $181,473 |
Mar 27, 2025 Mackaness James H |
Mackaness James H
CFO
|
Sell |
387 | $70.73 | 387 $70.73 $27,374 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
23,475 | $66.95 | 23,475 $66.95 $1,571,717 |
Mar 27, 2025 Yen Kristen |
Yen Kristen
See Remarks
|
Sell |
6,891 | $68.79 | 6,891 $68.79 $474,019 |
TOP